Supply Chain/Logistics

Apr 01, 2010
BioPharm International
The ability to deal with the complexity of the clinical supply process has shifted the balance of power to clinical supply chain specialists.
Mar 01, 2010
BioPharm International
Sharing information is a critical part of security—whether we're protecting travelers from bombs or patients from adulterated medicines.
Nov 01, 2009
BioPharm International
An enterprise-wide quality management initiative is required to maintain supplier quality without sacrificing bottom-line objectives.
Oct 01, 2009
BioPharm International
Small changes can have a big effect further downstream in your manufacturing processes.
May 13, 2009
BioPharm International
Members of the pharmaceutical and biotech industries have formed a new industry coalition, called "Rx-360," with the goal of improving supply chain safety.
Feb 11, 2009
BioPharm International
By BioPharm International Editors
The US Food and Drug Administration has launched a voluntary pilot program that will help promote the safety of drugs and active drug ingredients produced outside the United States.
Feb 11, 2009
BioPharm International
By BioPharm International Editors
With counterfeit and adulterated medicines posing an increasing risk to patients in the United States and worldwide, the US Pharmacopeial (USP, Rockville, MD) Convention announced on February 4, new standards for two widely used drug products that have been involved in episodes of adulteration resulting in patient deaths.
Jun 11, 2008
BioPharm International
By BioPharm International Editors
Felix M. Negron, senior vice president at Pall Corporation (East Hills, NY), has been appointed to lead global manufacturing and supply chain operations for the company’s life sciences business.
May 01, 2008
BioPharm International
By BioPharm International Editors
Recent problems with food and pharmaceutical ingredients sourced from China highlight a major disadvantage of our complex international supply chains for food and drug ingredients. A global supply chain offers more opportunities for accidental contamination as well as intentional adulteration and counterfeiting. Sticking to minimal requirements may not be enough.
Apr 01, 2008
BioPharm International
Now is a good time for companies to know their suppliers well.
native1_300x100
lorem ipsum